Mark N. Lampert is 10% Owner at CTI BIOPHARMA CORP (CTIC). They have made 30 open-market trades across 21 companies since 2009, most recently 2022-08-09.
CIK 0001233840
24 open-market purchases totalling $69.9M since 2010, against 6 sales. Across 16 scored buys the stock is up 10.9% at ninety days, and 9.7 points ahead of the S&P over the same stretch.
17 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 53% | 44% |
| Avg Move | -5.6% | +4.5% | +10.9% |
| Alpha | -36.7% | +2.9% | +9.7% |
| Scored | 17 | 17 | 16 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTIC | SELL | 2022-08-09 | 2022-08-11 | $6.12 | $104.0M | +8.7% | +12.9% | -1.0% |
| MRUS | BUY | 2021-03-30 | 2021-04-01 | $19.75 | $8.6M | +3.9% | +1.9% | -5.7% |
| MRUS | BUY | 2021-03-16 | 2021-03-18 | $23.00 | $5.8M | -11.1% | -2.9% | -8.0% |
| XOMA | BUY | 2019-12-19 | 2019-12-20 | $22.00 | $8.2M | +11.5% | +0.6% | -33.8% |
| CALA | BUY | 2019-11-20 | 2019-11-22 | $3.91 | $1.5M | +7.5% | +44.8% | +86.9% |
| CALA | BUY | 2019-11-14 | 2019-11-18 | $3.37 | $829K | +38.6% | +18.3% | +104.2% |
| FPRX | BUY | 2019-10-29 | 2019-10-31 | $3.88 | $114K | -3.0% | -2.2% | +30.0% |
| CTIC | BUY | 2018-02-09 | 2018-02-12 | $3.00 | $19.0M | +14.5% | +22.0% | +22.9% |
| XENE | BUY | 2017-06-21 | 2017-06-23 | $4.00 | $82K | -22.6% | -20.2% | -31.0% |
| NVLS | BUY | 2017-05-30 | 2017-06-01 | $2.27 | $107K | -3.0% | +5.7% | N/A |
| PTN | SELL | 2014-02-14 | 2014-02-19 | $1.17 | $357K | +214.8% | +52.3% | +52.3% |
| ONTY | BUY | 2013-08-08 | 2013-08-12 | $1.65 | $426K | N/A | N/A | N/A |
| RIGL | BUY | 2013-06-07 | 2013-06-11 | $3.47 | $113K | -8.6% | -5.6% | -5.6% |
| TRGT | BUY | 2012-11-14 | 2012-11-19 | $4.06 | $5.2M | N/A | N/A | N/A |
| CCXI | BUY | 2012-11-06 | 2012-11-08 | $12.00 | $480K | -48.7% | -9.1% | -9.1% |
| TRGT | BUY | 2012-10-31 | 2012-11-02 | $4.05 | $566K | N/A | N/A | N/A |
| LGND | BUY | 2012-10-26 | 2012-11-02 | $15.19 | $252K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2011-10-26 | 2011-10-28 | $13.91 | $84K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2011-10-12 | 2011-10-14 | $13.65 | $1.0M | -9.9% | -3.4% | -3.4% |
| ICGN | BUY | 2011-09-07 | 2011-09-09 | $6.00 | $760K | N/A | N/A | N/A |
| CAPS | BUY | 2011-08-18 | 2011-08-22 | $0.26 | $21K | -14.9% | +11.4% | +11.4% |
| CAPS | BUY | 2011-07-20 | 2011-07-22 | $0.25 | $63K | -14.9% | +11.4% | +11.4% |
| CAPS | BUY | 2011-07-14 | 2011-07-18 | $0.25 | $90K | -14.9% | +11.4% | +11.4% |
| CRA | BUY | 2011-05-06 | 2011-05-10 | $8.05 | $12.7M | N/A | N/A | N/A |
| CRA | BUY | 2011-04-05 | 2011-04-07 | $8.21 | $1.5M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| XOMA | 937,353 | $37.8M |
| ARRY | 7,058,997 | $24.1M |
| XENE | 336,468 | $11.3M |
| NVLS | 675,037 | $6.5M |
| PTN | 530,923 | $3.2M |
| CALA | 672,682 | $2.2M |
| CAPS | 3,993,637 | $340K |
| NVUS | 15,537 | $227K |
| CTIC | 19,839 | $180K |
| RAIN | 152,176 | $95K |
| AVGN | 7,837,189 | — |
| ONTY | 4,758,891 | — |
| ICGN | 625,400 | — |
| CRA | 14,210,217 | — |
| TRGT | 2,646,619 | — |
| FACT | 3,777,259 | — |
| NTII | 3,024,491 | — |
| ADLR | 4,406,551 | — |
| Total | $970.2M |
Shares reported on the most recent Form 4, priced at the 2022-08-11 close. 8 holdings could not be priced and are excluded from the total.